Abstract:Lung cancer is a well-known malignant tumor of the respiratory tract, which has caused a significant level of damage to human health. Micro-RNAs (miRNAs) are tiny, non-coding RNA stem-loop structures with a length of roughly 2025 nucleotides that function as powerful modulators of mRNA and protein products of a gene. miRNAs may modulate many biological processes involving growth, differentiation, proliferation, and cell death and play a key role in the pathogenesis of various types of malignancies. Several accumulating pieces of evidence have proven that miRNA, especially miR-146a, are crucial modulators of innate immune response sequences. A novel and exciting cancer research field has involved miRNA for the detection and suppression of cancer. However, the actual mechanism which is adopted by these miRNA is still unclear. miRNAs have been used as a cancer-associated biomarker in several studies, suggesting their altered expression in various cancers compared to the normal cells. The amount of expression of miRNA can also be used to determine the stage of the disease, aiding in early detection. In breast, pancreatic, and hepatocellular carcinoma, and gastric cancer, cancer cell proliferation and metastasis has been suppressed by miR-146a. Changes in miR-146a expression levels have biomarker importance and possess a high potential as a therapeutic target in lung cancer. It retards epithelial-mesenchymal transition and promotes the therapeutic action of anticancer agents in lung cancer. Studies have also suggested that miR-146a affects gene expression through different signaling pathways viz: TNF-, NF-B and MEK-1/2, and JNK-1/2. Further research is required for understanding the molecular mechanisms of miR-146a in lung cancer. The potential role of miR-146a as a diagnostic marker of lung cancer must also be analyzed. This review summarizes the tumor-suppressing, anti-inflammatory, and antichemoresistive nature of miR-146a in lung cancer.

MicroRNAs modulation in lung cancer: exploring dual mechanisms and clinical prospects

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer

MicroRNA-targeted therapeutics for lung cancer treatment

MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential

Involvement of Micrornas in Lung Cancer Biology and Therapy

Micro-RNAs and lung cancer: A focus on signaling pathways and therapeutics

[A Review of Epigenetic Modifications Regulate MicroRNA Expression in Lung Cancer]

MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment.

Regulatory mechanisms of microRNAs in lung cancer stem cells

Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer

Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review

Research Progress on Lung Cancer Related MicroRNAs

Systematic analysis reveals key microRNAs as diagnostic and prognostic factors in progressive stages of lung cancer

In-depth Bioinformatic Analysis of Lung Cancer-Associated Microrna Targets

Pathophysiology of miR-146a in lung cancer. Prospects of rising of efficiency of targeted therapy

Mechanisms of microRNA Regulation of the Epithelial–Mesenchymal Transition (EMT) in Lung Cancer

The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer

miR-137: a potential therapeutic target for lung cancer

The Potential Clinical Applications and Prospects of Micrornas in Lung Cancer.

Roles of Microrna in Diagnosis, Therapy and Prognosis of Lung Cancer